![Stephen Basso](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Basso
Director of Finance/CFO at
INNOVIVA, INC.
Net worth: 2 M $ as of 2026-05-30
Profile
Stephen Basso currently serves as Treasurer & Director at La Jolla Pharmaceutical Co., Chief Financial Officer at Innoviva, Inc. since 2023, and Treasurer at Tetraphase Pharmaceuticals, Inc. Formerly, Mr. Basso was Vice President-North America Commercial at Alexion Pharmaceuticals, Inc. from 2016 to 2017, Chief Financial Officer & Senior VP-Finance at Inozyme Pharma, Inc. from 2020 to 2021, and Chief Operating & Financial Officer at Cybrexa, Inc. Education includes an MBA from Boston College and an undergraduate degree from Providence College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INNOVIVA, INC. 0.12% | 2026-05-19 | 88,571 ( 0.12% ) | 2 M $ | 2026-05-30 |
Stephen Basso active positions
| Companies | Position | Start |
|---|---|---|
| INNOVIVA, INC. | Director of Finance/CFO | 2023-08-20 |
| LA JOLLA PHARMACEUTICAL COMPANY | Director/Board Member | - |
| TETRAPHASE PHARMACEUTICALS, INC. | Treasurer | - |
Former positions of Stephen Basso
| Companies | Position | End |
|---|---|---|
| INOZYME PHARMA, INC. | Director of Finance/CFO | 2021-05-13 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-04-30 |
Cybrexa, Inc.
 Cybrexa, Inc. BiotechnologyHealth Technology Develops molecule DNA repair inhibitors that directly target the tumor microenvironment | Director of Finance/CFO | - |
Training of Stephen Basso
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
55
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Providence College
 Providence College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inozyme Pharma, Inc.
 Inozyme Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
Cybrexa, Inc.
Cybrexa, Inc. BiotechnologyHealth Technology Develops molecule DNA repair inhibitors that directly target the tumor microenvironment | Health Technology |
- Stock Market
- Insiders
- Stephen Basso
